Amoxyclav 625 is a co-formulation consisting of Amoxicillin (500mg) and Clavulanic Acid (125mg). Amoxicillin is a broad-spectrum semi-synthetic antibiotic, but its vulnerability to beta-lactamase enzymes produced by resistant bacteria often limits its use. The "Information Gain" here lies in the Clavulanate addition; it acts as a "suicide inhibitor," binding to beta-lactamase and allowing Amoxicillin to reach its bacterial target effectively.
In developing regions, Amoxyclav 625 is the frontline defense against Community-Acquired Pneumonia (CAP) and acute bacterial sinusitis. In urban healthcare settings, it is widely utilized for post-operative dental prophylaxis and skin/soft tissue infections. Our products are formulated to remain stable in both tropical (Zone IVb) and temperate climates.
China's pharmaceutical industry offers unparalleled economies of scale and vertical integration. Our factories utilize advanced Pre-Mix and Co-Crystallization technologies to ensure the Clavulanate (which is highly moisture-sensitive) maintains its potency throughout the shelf life. Our supply chain resilience ensures consistent delivery even during global logistics fluctuations.
The global pharmaceutical market is shifting toward Precision Sourcing. Procurement officers are no longer looking for the lowest price; they are seeking Reliability and Transparency.
We provide full dossiers in CTD format to facilitate quick approval by local Ministries of Health (MOH). Our expertise in BP/USP/EP standards ensures seamless market entry in over 50 countries.
While tablets are stable, our "Serum Pharma" pedigree allows us to manage complex multi-modal logistics, ensuring that raw materials and finished products are protected from extreme humidity and temperature.
Beyond the standard 625mg, we offer customization in Bio-Fermentation and Pre-mix services for specialized pediatric or geriatric dosages, tailored to specific regional health needs.
Serum Pharma continuously monitors the development of cutting-edge markets. We specialize in the customization of innovative delivery systems and production techniques.
Optimized ingredient blending for maximum bioavailability and absorption speeds.
Advanced molecular engineering to improve the stability and solubility of active pharmaceutical ingredients (APIs).
Leveraging high-tech fermentation processes for sustainable and high-purity raw material production.
Amoxyclav 625 is used to treat a wide range of bacterial infections including respiratory tract infections (bronchitis, pneumonia), urinary tract infections, skin and soft tissue infections, and dental infections. It is particularly effective against bacteria that have developed resistance to amoxicillin alone.
Many bacteria produce an enzyme called beta-lactamase that destroys amoxicillin. Clavulanic acid inhibits these enzymes, effectively protecting the amoxicillin and allowing it to kill the bacteria.
We provide a combination of competitive "Wholesale" pricing, GMP-certified quality assurance, and a decade of export experience. Our products undergo rigorous stability testing to ensure they maintain efficacy in diverse global climates.
Yes, we offer comprehensive OEM services, including custom packaging design and formulation adjustments to meet local market requirements, backed by full regulatory documentation.
We follow a strict SOP for quality feedback. Every batch has a retained sample for re-testing. In the rare event of a quality issue, our technical team provides a full root-cause analysis and corrective action report.
